临研通拥有超过50人的专业化数字化团队，涵盖产品经理，UX，前端，后端，算法工程师等各职能;
临研通4年时间完成10多项数字化产品开发，获得54项软件作权，7项发明专利，3项实用新型专利;
临研通智能监测平台与观严医疗互联网医院系统均获得公安部三级等保认证，
临研通旗下观严大药房管理系统成功对接医保监管平台与药监系统信息监管平台;
临研通数字化平台累计支持628项临床研究在线运行，涉及用户超95,000名;
临研通DIP产品支持国家医学研究中心协同网络平台建设，支持超200家医院在线交互;
临研通独立构建集临床研究与医疗为一体的AI大模型Totrial-Driver;
临研通团队累计接受数十家企事业单位定制化临床研究数字化产品的开发;
Linyantong boasts a specialized digital team of over 50 members, covering various roles including product managers, UX designers, front-end and back-end engineers, and algorithm engineers.
Over four years, Linyantong has completed the development of more than 10 digital products, obtaining 54 software copyrights, 7 invention patents, and 3 utility model patents.
Both Linyantong’s intelligent monitoring platform and Guanyan Medical’s internet hospital system have achieved Level 3 cybersecurity certification from the Ministry of Public Security.
Linyantong’s Guanyan Pharmacy Management System has successfully connected with the medical insurance regulatory platform and the drug regulatory information platform.
Linyantong’s digital platform has supported the online operation of 628 clinical studies, involving over 95,000 users.
Linyantong’s DIP product supports the construction of the National Medical Research Center Collaborative Network Platform, enabling online interaction for over 200 hospitals.
Linyantong independently developed Totrial-Driver, an AI large model integrating clinical research and healthcare.
The Linyantong team has undertaken the development of customized clinical research digital products for dozens of enterprises and institutions.
临研通4年时间完成10多项数字化产品开发，获得54项软件作权，7项发明专利，3项实用新型专利;
临研通智能监测平台与观严医疗互联网医院系统均获得公安部三级等保认证，
临研通旗下观严大药房管理系统成功对接医保监管平台与药监系统信息监管平台;
临研通数字化平台累计支持628项临床研究在线运行，涉及用户超95,000名;
临研通DIP产品支持国家医学研究中心协同网络平台建设，支持超200家医院在线交互;
临研通独立构建集临床研究与医疗为一体的AI大模型Totrial-Driver;
临研通团队累计接受数十家企事业单位定制化临床研究数字化产品的开发;
Linyantong boasts a specialized digital team of over 50 members, covering various roles including product managers, UX designers, front-end and back-end engineers, and algorithm engineers.
Over four years, Linyantong has completed the development of more than 10 digital products, obtaining 54 software copyrights, 7 invention patents, and 3 utility model patents.
Both Linyantong’s intelligent monitoring platform and Guanyan Medical’s internet hospital system have achieved Level 3 cybersecurity certification from the Ministry of Public Security.
Linyantong’s Guanyan Pharmacy Management System has successfully connected with the medical insurance regulatory platform and the drug regulatory information platform.
Linyantong’s digital platform has supported the online operation of 628 clinical studies, involving over 95,000 users.
Linyantong’s DIP product supports the construction of the National Medical Research Center Collaborative Network Platform, enabling online interaction for over 200 hospitals.
Linyantong independently developed Totrial-Driver, an AI large model integrating clinical research and healthcare.
The Linyantong team has undertaken the development of customized clinical research digital products for dozens of enterprises and institutions.